Geode Capital Management, LLC Sellas Life Sciences Group, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 733,546 shares of SLS stock, worth $931,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares

733,546

Previous 605,191 21.21%

Holding current value

$931,603

Previous $756,000 2.12%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.84 - $1.35 $107,818 - $173,279	128,355 Added 21.21%	733,546 $740,000
Q3 2024 Nov 12, 2024	BUY	$1.08 - $1.39 $95,237 - $122,574	88,183 Added 17.06%	605,191 $756,000
Q2 2024 Aug 09, 2024	BUY	$1.06 - $1.63 $258,581 - $397,630	243,945 Added 89.34%	517,008 $615,000
Q1 2024 May 13, 2024	BUY	$0.51 - $1.55 $14,004 - $42,563	27,460 Added 11.18%	273,063 $275,000
Q4 2023 Feb 13, 2024	BUY	$0.88 - $1.57 $8,800 - $15,700	10,000 Added 4.24%	245,603 $260,000
Q3 2023 Nov 13, 2023	BUY	$1.42 - $1.83 $67,502 - $86,992	47,537 Added 25.28%	235,603 $386,000
Q4 2022 Feb 13, 2023	BUY	$1.8 - $5.41 $78,024 - $234,507	43,347 Added 29.95%	188,066 $443,000
Q2 2022 Aug 12, 2022	BUY	$2.14 - $4.15 $16,741 - $32,465	7,823 Added 5.71%	144,719 $322,000
Q1 2022 May 13, 2022	BUY	$4.73 - $7.18 $14,639 - $22,222	3,095 Added 2.31%	136,896 $914,000
Q3 2021 Nov 12, 2021	BUY	$8.21 - $10.53 $266,529 - $341,845	32,464 Added 32.04%	133,801 $1.23 Million
Q2 2021 Aug 13, 2021	BUY	$7.19 - $13.71 $46,231 - $88,155	6,430 Added 6.78%	101,337 $1.12 Million
Q1 2021 May 12, 2021	BUY	$5.5 - $11.71 $332,706 - $708,361	60,492 Added 175.77%	94,907 $810,000
Q4 2020 Feb 12, 2021	SELL	$2.45 - $17.66 $64,922 - $467,972	-26,499 Reduced 43.5%	34,415 $199,000
Q3 2020 Nov 13, 2020	BUY	$1.88 - $3.58 $564 - $1,074	300 Added 0.49%	60,914 $161,000
Q2 2020 Aug 13, 2020	BUY	$1.53 - $3.93 $11,975 - $30,760	7,827 Added 14.83%	60,614 $177,000
Q1 2020 May 14, 2020	BUY	$1.7 - $4.08 $1,591 - $3,818	936 Added 1.81%	52,787 $91,000
Q4 2019 Feb 13, 2020	BUY	$3.79 - $10.5 $196,515 - $544,435	51,851 New	51,851 $222,000

Others Institutions Holding SLS

# of Institutions

Shares Held

7.08M

Call Options Held

1.8M

Put Options Held

49.7K

View Full List

About SELLAS Life Sciences Group, Inc.

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $26.1M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

More about SLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Sellas Life Sciences Group, Inc. Transaction History